======= WBSCR22 ======= == Gene Information == * **Official Symbol**: BUD23 * **Official Name**: BUD23 rRNA methyltransferase and ribosome maturation factor * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=114049|114049]] * **UniProt**: [[https://www.uniprot.org/uniprot/O43709|O43709]] * **Interactions**: [[https://thebiogrid.org/search.php?search=WBSCR22&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20WBSCR22|Open PubMed]] * **OMIM**: [[https://omim.org/entry/615733|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: S-adenosyl-L-methionine-dependent methyltransferase that specifically methylates the N(7) position of a guanine in 18S rRNA (PubMed:25851604). Requires the methyltransferase adapter protein TRM112 for full rRNA methyltransferase activity (PubMed:25851604). Involved in the pre-rRNA processing steps leading to small-subunit rRNA production independently of its RNA-modifying catalytic activity (PubMed:25851604). Important for biogenesis end export of the 40S ribosomal subunit independent on its methyltransferase activity (PubMed:24086612). Locus-specific steroid receptor coactivator. Potentiates transactivation by glucocorticoid (NR3C1), mineralocorticoid (NR3C2), androgen (AR) and progesterone (PGR) receptors (PubMed:24488492). Required for the maintenance of open chromatin at the TSC22D3/GILZ locus to facilitate NR3C1 loading on the response elements (PubMed:24488492). Required for maintenance of dimethylation on histone H3 'Lys-79' (H3K79me2), although direct histone methyltransferase activity is not observed in vitro (PubMed:24488492). {ECO:0000250, ECO:0000269|PubMed:24086612, ECO:0000269|PubMed:24488492, ECO:0000269|PubMed:25851604}. |WBS methylT| |Methyltransf 11| |Methyltransf 18| |rRNA (guanine-N7)-methylation| |rRNA (guanine) methyltransferase activity| |RNA (guanine-N7)-methylation| |positive regulation of rRNA processing| |positive regulation of ribosome biogenesis| |rRNA base methylation| |regulation of rRNA processing| |regulation of ribosome biogenesis| |rRNA methylation| |rRNA modification| |methyltransferase activity| |RNA methylation| |RNA modification| |rRNA processing| |rRNA metabolic process| |macromolecule methylation| |ribosome biogenesis| |methylation| |ncRNA processing| |ribonucleoprotein complex biogenesis| |ncRNA metabolic process| |protein heterodimerization activity| |positive regulation of cellular component biogenesis| |perinuclear region of cytoplasm| |chromatin organization| |nucleolus| |RNA processing| |regulation of cellular component biogenesis| |chromosome organization| |RNA binding| |RNA metabolic process| |positive regulation of RNA metabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of gene expression| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|-1.88| |[[:results:exp22|MLN-4924 2μM R00 exp22]]|-1.72| |[[:results:exp348|Cyclosporin-A 3μM R07 exp348]]|1.72| |[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|1.72| |[[:results:exp458|Bisphenol S 100μM R08 exp458]]|1.81| |[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|1.83| |[[:results:exp317|Geldanamycin 0.015 to 0.05μM on day4 R07 exp317]]|1.84| |[[:results:exp380|NMS-873 0.07μM R07 exp380]]|1.84| |[[:results:exp262|Alda-1 10μM R06 exp262]]|1.87| |[[:results:exp183|IU1-C 25μM R04 exp183]]|1.98| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|2| |[[:results:exp149|SB203580 25μM R03 exp149]]|2.04| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|2.11| |[[:results:exp140|Nicotinate 1000μM R03 exp140]]|2.15| |[[:results:exp318|ABT-702 5μM R07 exp318]]|2.23| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 720/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|28/28| |blood|27/28| |bone|25/25| |breast|33/33| |central nervous system|56/56| |cervix|4/4| |colorectal|16/17| |esophagus|13/13| |fibroblast|1/1| |gastric|15/15| |kidney|19/21| |liver|20/20| |lung|75/75| |lymphocyte|14/14| |ovary|26/26| |pancreas|24/24| |peripheral nervous system|16/16| |plasma cell|15/15| |prostate|1/1| |skin|23/24| |soft tissue|7/7| |thyroid|2/2| |upper aerodigestive|22/22| |urinary tract|29/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 325 * **Expression level (log2 read counts)**: 6.48 {{:chemogenomics:nalm6 dist.png?nolink |}}